Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis
Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Álvarez-Twose, Iván [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
1614 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward - Papakitsou, I. ELSEVIER, 2022, official publication of the American Academy of Allergy, Asthma and Immunology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:137 ; year:2016 ; number:1 ; pages:168-1781 ; extent:1614 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jaci.2015.05.008 |
|---|
| Katalog-ID: |
ELV019036280 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019036280 | ||
| 003 | DE-627 | ||
| 005 | 20230623145558.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaci.2015.05.008 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000181A.pica |
| 035 | |a (DE-627)ELV019036280 | ||
| 035 | |a (ELSEVIER)S0091-6749(15)00701-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.85 |2 bkl | ||
| 100 | 1 | |a Álvarez-Twose, Iván |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis |
| 264 | 1 | |c 2016 | |
| 300 | |a 1614 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. | ||
| 650 | 7 | |a mastocytosis |2 Elsevier | |
| 650 | 7 | |a imatinib |2 Elsevier | |
| 650 | 7 | |a Mast cell |2 Elsevier | |
| 650 | 7 | |a KIT |2 Elsevier | |
| 650 | 7 | |a well differentiated |2 Elsevier | |
| 700 | 1 | |a Jara-Acevedo, María |4 oth | |
| 700 | 1 | |a Morgado, José Mário |4 oth | |
| 700 | 1 | |a García-Montero, Andrés |4 oth | |
| 700 | 1 | |a Sánchez-Muñoz, Laura |4 oth | |
| 700 | 1 | |a Teodósio, Cristina |4 oth | |
| 700 | 1 | |a Matito, Almudena |4 oth | |
| 700 | 1 | |a Mayado, Andrea |4 oth | |
| 700 | 1 | |a Caldas, Carolina |4 oth | |
| 700 | 1 | |a Mollejo, Manuela |4 oth | |
| 700 | 1 | |a Orfao, Alberto |4 oth | |
| 700 | 1 | |a Escribano, Luis |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Papakitsou, I. ELSEVIER |t Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |d 2022 |d official publication of the American Academy of Allergy, Asthma and Immunology |g Amsterdam [u.a.] |w (DE-627)ELV000021164 |
| 773 | 1 | 8 | |g volume:137 |g year:2016 |g number:1 |g pages:168-1781 |g extent:1614 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jaci.2015.05.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.85 |j Kardiologie |j Angiologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 137 |j 2016 |e 1 |h 168-1781 |g 1614 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
i á t iát |
|---|---|
| matchkey_str |
lvareztwoseivnjaraacevedomaramorgadojosm:2016----:lnclmuohntpcnmlclrhrceitcowldfeet |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.85 |
| publishDate |
2016 |
| allfields |
10.1016/j.jaci.2015.05.008 doi GBV00000000000181A.pica (DE-627)ELV019036280 (ELSEVIER)S0091-6749(15)00701-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Álvarez-Twose, Iván verfasserin aut Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis 2016 1614 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated Elsevier Jara-Acevedo, María oth Morgado, José Mário oth García-Montero, Andrés oth Sánchez-Muñoz, Laura oth Teodósio, Cristina oth Matito, Almudena oth Mayado, Andrea oth Caldas, Carolina oth Mollejo, Manuela oth Orfao, Alberto oth Escribano, Luis oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:137 year:2016 number:1 pages:168-1781 extent:1614 https://doi.org/10.1016/j.jaci.2015.05.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 137 2016 1 168-1781 1614 045F 610 |
| spelling |
10.1016/j.jaci.2015.05.008 doi GBV00000000000181A.pica (DE-627)ELV019036280 (ELSEVIER)S0091-6749(15)00701-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Álvarez-Twose, Iván verfasserin aut Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis 2016 1614 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated Elsevier Jara-Acevedo, María oth Morgado, José Mário oth García-Montero, Andrés oth Sánchez-Muñoz, Laura oth Teodósio, Cristina oth Matito, Almudena oth Mayado, Andrea oth Caldas, Carolina oth Mollejo, Manuela oth Orfao, Alberto oth Escribano, Luis oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:137 year:2016 number:1 pages:168-1781 extent:1614 https://doi.org/10.1016/j.jaci.2015.05.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 137 2016 1 168-1781 1614 045F 610 |
| allfields_unstemmed |
10.1016/j.jaci.2015.05.008 doi GBV00000000000181A.pica (DE-627)ELV019036280 (ELSEVIER)S0091-6749(15)00701-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Álvarez-Twose, Iván verfasserin aut Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis 2016 1614 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated Elsevier Jara-Acevedo, María oth Morgado, José Mário oth García-Montero, Andrés oth Sánchez-Muñoz, Laura oth Teodósio, Cristina oth Matito, Almudena oth Mayado, Andrea oth Caldas, Carolina oth Mollejo, Manuela oth Orfao, Alberto oth Escribano, Luis oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:137 year:2016 number:1 pages:168-1781 extent:1614 https://doi.org/10.1016/j.jaci.2015.05.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 137 2016 1 168-1781 1614 045F 610 |
| allfieldsGer |
10.1016/j.jaci.2015.05.008 doi GBV00000000000181A.pica (DE-627)ELV019036280 (ELSEVIER)S0091-6749(15)00701-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Álvarez-Twose, Iván verfasserin aut Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis 2016 1614 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated Elsevier Jara-Acevedo, María oth Morgado, José Mário oth García-Montero, Andrés oth Sánchez-Muñoz, Laura oth Teodósio, Cristina oth Matito, Almudena oth Mayado, Andrea oth Caldas, Carolina oth Mollejo, Manuela oth Orfao, Alberto oth Escribano, Luis oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:137 year:2016 number:1 pages:168-1781 extent:1614 https://doi.org/10.1016/j.jaci.2015.05.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 137 2016 1 168-1781 1614 045F 610 |
| allfieldsSound |
10.1016/j.jaci.2015.05.008 doi GBV00000000000181A.pica (DE-627)ELV019036280 (ELSEVIER)S0091-6749(15)00701-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.85 bkl Álvarez-Twose, Iván verfasserin aut Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis 2016 1614 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated Elsevier Jara-Acevedo, María oth Morgado, José Mário oth García-Montero, Andrés oth Sánchez-Muñoz, Laura oth Teodósio, Cristina oth Matito, Almudena oth Mayado, Andrea oth Caldas, Carolina oth Mollejo, Manuela oth Orfao, Alberto oth Escribano, Luis oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:137 year:2016 number:1 pages:168-1781 extent:1614 https://doi.org/10.1016/j.jaci.2015.05.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 137 2016 1 168-1781 1614 045F 610 |
| language |
English |
| source |
Enthalten in Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward Amsterdam [u.a.] volume:137 year:2016 number:1 pages:168-1781 extent:1614 |
| sourceStr |
Enthalten in Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward Amsterdam [u.a.] volume:137 year:2016 number:1 pages:168-1781 extent:1614 |
| format_phy_str_mv |
Article |
| bklname |
Kardiologie Angiologie |
| institution |
findex.gbv.de |
| topic_facet |
mastocytosis imatinib Mast cell KIT well differentiated |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| authorswithroles_txt_mv |
Álvarez-Twose, Iván @@aut@@ Jara-Acevedo, María @@oth@@ Morgado, José Mário @@oth@@ García-Montero, Andrés @@oth@@ Sánchez-Muñoz, Laura @@oth@@ Teodósio, Cristina @@oth@@ Matito, Almudena @@oth@@ Mayado, Andrea @@oth@@ Caldas, Carolina @@oth@@ Mollejo, Manuela @@oth@@ Orfao, Alberto @@oth@@ Escribano, Luis @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000021164 |
| dewey-sort |
3610 |
| id |
ELV019036280 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019036280</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623145558.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaci.2015.05.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000181A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019036280</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0091-6749(15)00701-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Álvarez-Twose, Iván</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1614</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mastocytosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">imatinib</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mast cell</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">KIT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">well differentiated</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jara-Acevedo, María</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morgado, José Mário</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">García-Montero, Andrés</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sánchez-Muñoz, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teodósio, Cristina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matito, Almudena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mayado, Andrea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Caldas, Carolina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mollejo, Manuela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Orfao, Alberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Escribano, Luis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Papakitsou, I. ELSEVIER</subfield><subfield code="t">Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward</subfield><subfield code="d">2022</subfield><subfield code="d">official publication of the American Academy of Allergy, Asthma and Immunology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000021164</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:137</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:168-1781</subfield><subfield code="g">extent:1614</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaci.2015.05.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">137</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">168-1781</subfield><subfield code="g">1614</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Álvarez-Twose, Iván |
| spellingShingle |
Álvarez-Twose, Iván ddc 610 bkl 44.85 Elsevier mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis |
| authorStr |
Álvarez-Twose, Iván |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000021164 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.85 bkl Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated Elsevier |
| topic |
ddc 610 bkl 44.85 Elsevier mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated |
| topic_unstemmed |
ddc 610 bkl 44.85 Elsevier mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated |
| topic_browse |
ddc 610 bkl 44.85 Elsevier mastocytosis Elsevier imatinib Elsevier Mast cell Elsevier KIT Elsevier well differentiated |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m j a mja j m m jm jmm a g m agm l s m lsm c t ct a m am a m am c c cc m m mm a o ao l e le |
| hierarchy_parent_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| hierarchy_parent_id |
ELV000021164 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000021164 |
| title |
Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis |
| ctrlnum |
(DE-627)ELV019036280 (ELSEVIER)S0091-6749(15)00701-0 |
| title_full |
Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis |
| author_sort |
Álvarez-Twose, Iván |
| journal |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| journalStr |
Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
168 |
| author_browse |
Álvarez-Twose, Iván |
| container_volume |
137 |
| physical |
1614 |
| class |
610 610 DE-600 610 VZ 44.85 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Álvarez-Twose, Iván |
| doi_str_mv |
10.1016/j.jaci.2015.05.008 |
| dewey-full |
610 |
| title_sort |
clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis |
| title_auth |
Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis |
| abstract |
Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. |
| abstractGer |
Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. |
| abstract_unstemmed |
Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis |
| url |
https://doi.org/10.1016/j.jaci.2015.05.008 |
| remote_bool |
true |
| author2 |
Jara-Acevedo, María Morgado, José Mário García-Montero, Andrés Sánchez-Muñoz, Laura Teodósio, Cristina Matito, Almudena Mayado, Andrea Caldas, Carolina Mollejo, Manuela Orfao, Alberto Escribano, Luis |
| author2Str |
Jara-Acevedo, María Morgado, José Mário García-Montero, Andrés Sánchez-Muñoz, Laura Teodósio, Cristina Matito, Almudena Mayado, Andrea Caldas, Carolina Mollejo, Manuela Orfao, Alberto Escribano, Luis |
| ppnlink |
ELV000021164 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jaci.2015.05.008 |
| up_date |
2024-07-06T20:24:00.430Z |
| _version_ |
1803862608896327680 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019036280</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623145558.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaci.2015.05.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000181A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019036280</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0091-6749(15)00701-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Álvarez-Twose, Iván</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1614</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Well-differentiated systemic mastocytosis (WDSM) is a rare variant of systemic mastocytosis (SM) characterized by bone marrow (BM) infiltration by mature-appearing mast cells (MCs) often lacking exon 17 KIT mutations. Because of its rarity, the clinical and biological features of WDSM remain poorly defined.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">mastocytosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">imatinib</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mast cell</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">KIT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">well differentiated</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jara-Acevedo, María</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morgado, José Mário</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">García-Montero, Andrés</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sánchez-Muñoz, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teodósio, Cristina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matito, Almudena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mayado, Andrea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Caldas, Carolina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mollejo, Manuela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Orfao, Alberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Escribano, Luis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Papakitsou, I. ELSEVIER</subfield><subfield code="t">Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward</subfield><subfield code="d">2022</subfield><subfield code="d">official publication of the American Academy of Allergy, Asthma and Immunology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000021164</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:137</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:168-1781</subfield><subfield code="g">extent:1614</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaci.2015.05.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">137</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">168-1781</subfield><subfield code="g">1614</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.39989 |